JB Meigs, MA Mittleman, DM Nathan, GH Tofler, DE … - Jama, 2000 - Am Med Assoc Context Increased risk for cardiovascular disease in persons with glucose intolerance (impaired
glucose tolerance and type 2 diabetes mellitus) is not fully explained by concomitant elevations in
traditional atherosclerosis risk ... Cited by 424 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org AR Collins, WP Meehan, U Kintscher, S … - … , and vascular biology, 2001 - Am Heart Assoc Abstract—Peroxisome proliferator–activated receptor- (PPAR ) is a ligand-activated nuclear
receptor expressed in all of the major cell types found in atherosclerotic lesions:
monocytes/macrophages, endothelial ... Cited by 340 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org JB Meigs, PF Jacques, J Selhub, DE Singer, DM … - Diabetes Care, 2001 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We measured clinical characteristics, plasma levels of fasting
homocysteine, folate, B vitamins, creatinine, and fasting and 2-h insulin and glucose levels after a
75-g oral glucose tolerance test in ... Cited by 177 - Related articles - BL Direct - All 8 versions
PW Wahl, PJ Savage, BM Psaty, TJ Orchard, JA … - The Lancet, 1998 - Elsevier In the 1989 cohort, the prevalence of untreated diabetes with ADA diagnostic fasting criteria was
7·7% versus a prevalence of 14·8% by the WHO criteria. In the African-American cohort, the
prevalence of untreated diabetes ... Cited by 162 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org WA Hsueh, RE Law - Arteriosclerosis, thrombosis, and vascular biology, 2001 - Am Heart Assoc Atherosclerosis is a major vascular complication of diabetes and the primary cause of mortality in
persons with this disease. Metabolic abnormalities related to the Insulin Resistance Syndrome or
Metabolic Syndrome may importantly ... Cited by 148 - Related articles - BL Direct - All 9 versions
ES Huang, JB Meigs, DE Singer - The American journal of medicine, 2001 - Elsevier Seven serum cholesterol-lowering trials, six blood pressure–lowering trials, and five blood
glucose-lowering trials met eligibility criteria. For aggregate cardiac events (coronary heart
disease death and nonfatal ... Cited by 144 - Related articles - BL Direct - All 12 versions
- ►diabetesjournals.org [PDF] M Buysschaert, AS Dramais, PE Wallemacq, MP … - Diabetes Care, 2000 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS — A total of 122 consecutive type 2 diabetic in- and outpa- tient
subjects (40 men and 82 women) par- ticipated in the study. Their age and diabetes duration (mean ±
1 SD) were 63 ± 10 and 14 ± 9 ... Cited by 121 - Related articles - BL Direct - All 9 versions
- ►oxfordjournals.org [PDF] N Suskin, RS McKelvie, RJ Burns, R Latini, D … - European heart …, 2000 - Eur Soc Cardiology Page 1. European Heart Journal (2000) 21, 1368–1375 doi:10.1053/euhj.1999.2043, available
online at http://www.idealibrary.com on Glucose and insulin abnormalities relate to functional
capacity in patients with congestive heart failure N. Suskin ... Cited by 113 - Related articles - BL Direct - All 3 versions
JB Meigs, DE Singer, LM Sullivan, KA Dukes, RB D' … - The American journal of …, 1997 - Elsevier RESULTS: The mean age of participants was 63 years (range 31 to 91); 51% were women. The mean
duration of NIDDM was 9 years (range <1 to 50), 35% took insulin, and 48% took sulfonylureas. Mean
glycohemoglobin was 10.6%. Sixty ... Cited by 109 - Related articles - BL Direct - All 7 versions
